Literature DB >> 23252880

Dependence of QSAR models on the selection of trial descriptor sets: a demonstration using nanotoxicity endpoints of decorated nanotubes.

Chi-Yu Shao1, Sing-Zuo Chen, Bo-Han Su, Yufeng J Tseng, Emilio Xavier Esposito, Anton J Hopfinger.   

Abstract

Little attention has been given to the selection of trial descriptor sets when designing a QSAR analysis even though a great number of descriptor classes, and often a greater number of descriptors within a given class, are now available. This paper reports an effort to explore interrelationships between QSAR models and descriptor sets. Zhou and co-workers (Zhou et al., Nano Lett. 2008, 8 (3), 859-865) designed, synthesized, and tested a combinatorial library of 80 surface modified, that is decorated, multi-walled carbon nanotubes for their composite nanotoxicity using six endpoints all based on a common 0 to 100 activity scale. Each of the six endpoints for the 29 most nanotoxic decorated nanotubes were incorporated as the training set for this study. The study reported here includes trial descriptor sets for all possible combinations of MOE, VolSurf, and 4D-fingerprints (FP) descriptor classes, as well as including and excluding explicit spatial contributions from the nanotube. Optimized QSAR models were constructed from these multiple trial descriptor sets. It was found that (a) both the form and quality of the best QSAR models for each of the endpoints are distinct and (b) some endpoints are quite dependent upon 4D-FP descriptors of the entire nanotube-decorator complex. However, other endpoints yielded equally good models only using decorator descriptors with and without the decorator-only 4D-FP descriptors. Lastly, and most importantly, the quality, significance, and interpretation of a QSAR model were found to be critically dependent on the trial descriptor sets used within a given QSAR endpoint study.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23252880     DOI: 10.1021/ci3005308

Source DB:  PubMed          Journal:  J Chem Inf Model        ISSN: 1549-9596            Impact factor:   4.956


  6 in total

1.  Computer-aided design of carbon nanotubes with the desired bioactivity and safety profiles.

Authors:  Denis Fourches; Dongqiuye Pu; Liwen Li; Hongyu Zhou; Qingxin Mu; Gaoxing Su; Bing Yan; Alexander Tropsha
Journal:  Nanotoxicology       Date:  2015-11-02       Impact factor: 5.913

2.  Decrypting Strong and Weak Single-Walled Carbon Nanotubes Interactions with Mitochondrial Voltage-Dependent Anion Channels Using Molecular Docking and Perturbation Theory.

Authors:  Michael González-Durruthy; Adriano V Werhli; Vinicius Seus; Karina S Machado; Alejandro Pazos; Cristian R Munteanu; Humberto González-Díaz; José M Monserrat
Journal:  Sci Rep       Date:  2017-10-16       Impact factor: 4.379

Review 3.  Practices and Trends of Machine Learning Application in Nanotoxicology.

Authors:  Irini Furxhi; Finbarr Murphy; Martin Mullins; Athanasios Arvanitis; Craig A Poland
Journal:  Nanomaterials (Basel)       Date:  2020-01-08       Impact factor: 5.076

4.  A safe-by-design tool for functionalised nanomaterials through the Enalos Nanoinformatics Cloud platform.

Authors:  Dimitra-Danai Varsou; Antreas Afantitis; Andreas Tsoumanis; Georgia Melagraki; Haralambos Sarimveis; Eugenia Valsami-Jones; Iseult Lynch
Journal:  Nanoscale Adv       Date:  2018-11-05

5.  Integration among databases and data sets to support productive nanotechnology: Challenges and recommendations.

Authors:  Sandra Karcher; Egon L Willighagen; John Rumble; Friederike Ehrhart; Chris T Evelo; Martin Fritts; Sharon Gaheen; Stacey L Harper; Mark D Hoover; Nina Jeliazkova; Nastassja Lewinski; Richard L Marchese Robinson; Karmann C Mills; Axel P Mustad; Dennis G Thomas; Georgia Tsiliki; Christine Ogilvie Hendren
Journal:  NanoImpact       Date:  2018-01

Review 6.  Understanding Nanoparticle Toxicity to Direct a Safe-by-Design Approach in Cancer Nanomedicine.

Authors:  Jossana A Damasco; Saisree Ravi; Joy D Perez; Daniel E Hagaman; Marites P Melancon
Journal:  Nanomaterials (Basel)       Date:  2020-11-02       Impact factor: 5.076

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.